Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.45 USD | +0.23% | -6.67% | +71.65% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+71.65% | 3.12B | |
+9.50% | 115B | |
+11.61% | 106B | |
-2.39% | 21.96B | |
-13.62% | 21.87B | |
-5.29% | 19.21B | |
-4.60% | 18.08B | |
-38.29% | 17.71B | |
+7.51% | 14.32B | |
+36.11% | 12.42B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Transcript : Summit Therapeutics Inc., Q1 2023 Earnings Call, May 11, 2023